Sort
11,323 grants matching “glioblastoma”
Clinical and Translational Oncology Program (CTOP)
$79,506Steffan T Nawrocki · University Of Arizona · P30 · FY2024 · CA
Clinical and Translational Oncology Program (CTOP)
$79,506Steffan T Nawrocki · University Of Arizona · P30 · FY2023 · CA
Role of mismatch repair in regulating effects of PARP inhibition in Glioblastoma
$79,500Shiv Kumar Gupta · Mayo Clinic Rochester · R03 · FY2018 · CA
Chemoprevention of Gliomas using Nitrones with Anti-c-Met Activity
$79,500Rheal A Towner · Oklahoma Medical Research Foundation · R03 · FY2009 · CA
Role of mismatch repair in regulating effects of PARP inhibition in Glioblastoma
$79,500Shiv Kumar Gupta · Mayo Clinic Rochester · R03 · FY2017 · CA
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
$79,335Jian Hu · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma
$79,250Masahiro Hitomi · Cleveland Clinic Lerner Com-Cwru · R03 · FY2018 · CA
p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage
$79,250Hyeonjoo Cheon · Cleveland Clinic Lerner Com-Cwru · R03 · FY2017 · CA
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma
$79,250Masahiro Hitomi · Cleveland Clinic Lerner Com-Cwru · R03 · FY2017 · CA
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
$79,052Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2024 · CA
Characterization of Ras/Akt/CFIm25/APA signaling in Glioblastoma Development and Progression
$79,000Ping Ji · University Of Texas Med Br Galveston · R03 · FY2019 · CA
Leveraging Gα12 signaling to treat glioblastoma
$79,000Olga Chaim · University Of California, San Diego · R03 · FY2023 · NS
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
$78,892Klaske Marijke Schukken · Yale University · F32 · FY2024 · CA
Characterization of Ras/Akt/CFIm25/APA signaling in Glioblastoma Development and Progression
$78,875Ping Ji · University Of Texas Med Br Galveston · R03 · FY2018 · CA
NEUROONCOLOGY
$78,870Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2002 · CA
NEUROONCOLOGY
$78,870Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2002 · CA
Identification of enzymes inhibited by oncometabolites in Succinate Dehydrogenase mutant tumors
$78,750Lawrence S Kirschner · Ohio State University · R03 · FY2024 · CA
Identification of enzymes inhibited by oncometabolites in Succinate Dehydrogenase mutant tumors
$78,750Lawrence S Kirschner · Ohio State University · R03 · FY2023 · CA
A Multipoint Injection Technology for Highly Efficient Convection-Enhanced Delivery of Gene-Based Therapeutics
$78,528Flavia Vitale · University Of Pennsylvania · R01 · FY2021 · NS
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$78,391Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2024 · EB
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$78,339Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2023 · NS
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$78,339Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2022 · NS
Role of SerpinA3 in the response of glioblastoma to cerebrospinal fluid
$78,250Hugo Guerrero-Cazares · Mayo Clinic Jacksonville · R03 · FY2018 · NS
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$78,134James K Turkson · University Of Hawaii At Manoa · R01 · FY2014 · CA
Investigating MicroRNAs and Their Regulatory Networks in Glioblastoma
$78,041Zhongming Zhao · Vanderbilt University · R03 · FY2013 · CA